Background-Endoscopic sphincterotomy (EST) is widely used for the removal of stones from the bile duct, but stones recur in about one fifth of patients. Aims-To investigate hepatic clearance by quantitative cholescintigraphy (QC) in patients after EST and to discern the relationship between biliary emptying and stone recurrence. Methods-One hundred and forty nine patients who had EST and clearance of the bile duct for choledocholithiasis were selected. All patients were confirmed to have complete EST by sphincter of Oddi manometry and underwent QC soon after normalisation of liver function. Regular clinical follow up was performed for each patient. Results-During a mean 36 month follow up, 22 (14.8%) patients developed recurrent stones in the bile duct. Irrespective of the status of the gall bladder, patients with recurrent stones had a slower hepatic clearance of radioisotope during QC compared with patients without stone recurrence, but only the diVerences in cholecystectomised patients had statistical significance. After carrying out multivariate analysis, one parameter of QC, percentage clearance of maximal count at 45 minutes, was found to be the only significant factor for stone recurrence. All recurrent stones in the common bile duct were successfully removed at endoscopy. Conclusion-Slower hepatic clearance as shown by QC is an important factor responsible for stone recurrence after sphincter ablation.
Endoscopic sphincterotomy (EST) is now widely used for the removal of stones from the common bile duct (CBD). In follow up studies after EST, 3-21% of patients developed recurrent CBD stones and up to 21% of patients with gall bladder in situ required subsequent cholecystectomy due to cholecystitis, particularly those patients with preexisting cholecystolithiasis or cystic duct obstruction. [1] [2] [3] [4] [5] [6] [7] [8] Recurrent biliary symptoms or new stone formation usually occur within the first one to two years after EST. 4 5 No gross abnormality of the bile duct has been noted in patients with recurrent biliary stones after EST, although sphincteric stenosis has been observed in some patients. 2 However, in a manometric study, Geenen et al observed that sphincteric stenosis is infrequent if EST has been performed with a mean incision length of 1.1 cm. 9 Besides sphincteric stenosis, biliary stasis and infection are other possible pathogenic factors in primary CBD stone formation. 10 11 Although bacteriocholia is common after sphincter ablation, symptomatic cholangitis does not occur when the clearance function of the biliary tree is excellent. 12 Impaired biliary emptying is hence believed to be the key factor for recurrent stones. In the present study, we have used quantitative cholescintigraphy to study biliary emptying in patients after EST and complete clearance of CBD stones, and have analysed the possible factors which are likely to influence biliary emptying and stone recurrence.
Materials and Methods

PATIENTS
Three hundred and forty six patients with choledocholithiasis underwent EST to remove stones from the bile duct between September 1990 and May 1994 in the Veterans General Hospital-Kaohsiung. Patients who agreed to undergo sphincter of Oddi manometry, quantitative cholescintigraphy, and regular follow up visits were included in this study. Patients with suspected retained biliary stones, other systemic diseases, gastric operation, or persistent abnormal liver function for more than 16 weeks were excluded.
FOLLOW UP STUDIES
After EST, all patients who were enrolled in this study underwent liver biochemical tests (including serum total bilirubin, albumin, alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase) every two weeks until all values returned to normal. Soon after normalisation of liver function, all patients underwent sphincter of Oddi manometry to confirm the complete success of EST, and quantitative cholescintigraphy (QC). The interval between sphincter of Oddi manometry and QC was less than one week. Patients were scheduled for follow up visits and liver function tests every three to six months after sphincter of Oddi manometry and QC. They were advised to consult us immediately if any biliary symptoms recurred. Abdominal sonography and endoscopic retrograde cholangiography were carried out whenever symptoms recurred or abnormal liver function was noted. Details of the study were explained to every patient, and written consent was obtained. The protocol was approved by the Research Committee of the Veterans General Hospital-Kaohsiung.
SPHINCTER OF ODDI MANOMETRY
Sphincter of Oddi manometry was performed using a triple lumen polyethylene catheter of 1.7 mm outer diameter which was introduced through the biopsy channel of a duodenoscope (Olympus JF 1T 20, Tokyo, Japan). The catheter was perfused with sterile distilled water at a rate of 0.25 ml/min by a pneumohydraulic capillary pump (Arndorfer Medical Specialties, Greendale, Wisconsin, USA). No medication was given during the sphincter of Oddi manometry. We calibrated the pressure of the catheter in the duodenal lumen to zero before cannulation into the bile duct. After deep cannulation, bile was aspirated from one lumen of the catheter to confirm the correct position of the catheter and 2 ml of bile was collected for microscopic examination to ensure the absence of parasitic ova and crystals. Pressure was measured first in the common bile duct, then in the sphincter of Oddi and the duodenum using the station pull through technique. A basal pressure of less than 10 mm Hg for the sphincter of Oddi, in addition to a wide opening of the common bile duct, was defined as a complete ablation of sphincteric function.
QUANTITATIVE CHOLESCINTIGRAPHY
Quantitative cholescintigraphy was performed after intravenous administration of 8 mCi (296 MBq) technetium-99m labelled sodium N-[N1-(2,6 diethylphenyl) carbamoylmethyl] iminodiacetate (EHIDA, Amersham International plc, Buckinghamshire, UK) to the patients after overnight fasting. Imaging was carried out using a large field gamma camera with a low energy, all purpose collimator (Siemen Orbiter 75, Chicago, Illinois, USA) connected to a computer (Microdelta, Chicago, Illinois, USA). Data were recorded with the patients in a supine position under the gamma camera. A continuous series of 60 frames of one minute duration each was stored on the computer disk for later analysis. Static views at one, two, four, and six hours were also recorded. A rectangular region of interest was identified and outlined over the right hepatic lobe and a time-activity curve was created. The time to reach maximal count (t max ), half time for hepatic clearance from t max (t 1/2 ) and hepatic clearance percentage of the maximal count at 45 minutes and 60 minutes (E45', E60') were recorded for comparison. 13 14 The reference values of the positive limit were t max =13 minutes, t 1/2 =30 minutes, E45'=57%, and E60'=72%. 13 
STATISTICS
The results are expressed as mean (SE). Student's t test was used to compare the diVerences between the two groups. If the variances of the two groups were not equal, the Mann-Whitney U test was used. Survival analysis by the Breslow method was used to compare the diVerences of the factor time (t max , t 1/2 ). The factors aVecting stone recurrence and hepatic clearance were analysed by the logistic regression model. The factors (sex, intact gall bladder, juxtapapillary diverticulum) in the regression model were classified as dummy variables (0,1). E45'>57% was used as the lower normal limit of hepatic clearance for the logistic regression. 13 A p value of less than 0.05 was considered to be significant.
Results
RECURRENCE OF STONES AFTER EST
One hundred and fifty four patients were enrolled in the study and five patients were excluded from analysis due to basal sphincteric pressure greater than 10 mm Hg. Of the remaining 149 patients, 57 patients had previously had cholecystectomy and 29 patients underwent a laparoscopic cholecystectomy within one week after EST; the other 63 patients had no further gall bladder surgery after EST due to either old age or absence of cholecystolithiasis. No parasitic ova or crystals were found in the bile in all 149 patients during sphincter of Oddi manometry. Table 1 presents the characteristics of the patients. During the 13-61 month (mean 36 month) follow up period, 11/86 (12.8%) cholecystectomised patients and 11/63 (17.5%) patients with an intact gall bladder developed recurrent CBD stones (p>0.05). Of the 11 patients with recurrent stones and an intact gall bladder, only four had stones in the gall bladder at the time of EST. There was no diVerence in the time of normalisation of liver function after EST between the patients with or without stone recurrence (4.6 (4.3) weeks versus 5.4 (4.6) weeks, p>0.05). Eleven patients (five cholecystectomised patients and six with an intact gall bladder) had biliary symptoms at the time of stone recurrence. All recurrent CBD stones were successfully removed at endoscopy. One patient with an intact gall bladder underwent a prophylactic cholecystectomy after endoscopic treatment for recurrent CBD stones; two other patients had elective cholecystectomy due to acute cholecystitis.
HEPATIC CLEARANCE AFTER EST
Patients with recurrent stones exhibited slower hepatic clearance than patients without recurrent stones; the diVerences between patients with or without recurrent stones in all param- 
Discussion
Quantitative cholescintigraphy is a noninvasive test to evaluate hepatic clearance and biliary emptying. 14 15 We chose the region of interest over the right liver to avoid higher background activity over the left liver and bile duct. 16 17 The slopes for disappearance of isotope from the region of the right liver, hilum, and CBD were virtually identical; hepatic clearance in the right liver is therefore comparable to biliary emptying of the CBD in the absence of biliary obstruction and parenchymal liver disease. 13 14 In asymptomatic control patients, more than half of the radioisotope was excreted 45 minutes after administration. 13 Impaired biliary emptying can be detected by QC even when results of the routine liver function tests are normal. 15 However, QC is not sensitive enough to diVerentiate between organic and functional disorders of the biliary tract, especially in patients with a dilated bile duct. 18 In the present study, organic obstruction of the biliary tract may be excluded by cholangiography soon after EST, normal liver function before QC, and low sphincteric basal pressure on sphincter of Oddi manometry. The abnormal time-activity curve of the QC observed for some patients in this study therefore suggests impaired emptying of the biliary tract. Elta et al have reported frequent occurrence of delayed biliary drainage in asymptomatic patients after cholecystectomy, by observing the 45 minute drainage of contrast media during endoscopic retrograde cholangiography. 19 The sphincter of Oddi acts as a passive resistor to control the delivery of bile into the duodenum; bile is thought to be freely emptied into the duodenum after sphincteric ablation. 15 However, in the present study, after complete EST, patients showed wide variation in the parameters of the time-activity curve (for example, 5-81% in E45') of the QC, indicating heterogeneous of biliary emptying in patients with CBD stones even after sphincter ablation. As patients with recurrent CBD stones exhibited slower biliary emptying than patients without recurrent CBD stones, slower biliary emptying may be assumed to be an important factor for recurrence of primary CBD stones.
The time-activity curve for QC of noncholecystectomised patients has been reported to be unreliable because the gall bladder influences CBD clearance.
14 In this study, diVerences in the mean parameters of QC were observed between the non-cholecystectomised patients with and without recurrent CBD stones although only E60' reached statistical significance. Therefore, QC may be considered to be a useful test to predict the recurrence of CBD stones in patients after EST, particularly in cholecystectomised patients. The 45 minute clearance rate (E45') of QC is the most sensitive parameter of the time-activity curve for the diagnosis of dysfunction of the sphincter of Oddi. 13 In this study, E45' was the only variable related to the recurrence of CBD stones; sensitivity was 90.9% in cholecystectomised patients and 81.8% in patients with an intact gall bladder, but specificity was only 57.3% in cholecystectomised patients and 38.4% in patients with an intact gall bladder. Mean follow up time in this study was 36 months, and recurrent choledocholithiasis may occur five years after EST, so the risk of recurrent choledocholithiasis still exists in aysmptomatic patients with delayed biliary emptying. 20 Absence of reduction or dilatation in the diameter of the CBD after EST has been found to occur in patients with persistent symptoms or residual stones, 21 22 but dilatation of the CBD was not observed to be a reliable factor for predicting recurrent CBD stones in this study. An intact gall bladder and CBD diameter were the factors having a significant influence on biliary emptying during QC.
The incidence of JPD increases with age 23 ; this may induce bacterial contamination of bile in patients with an incompetent sphincter resulting in primary CBD stone formation. 24 A JPD was present in 60% of our patients, probably due to their age (median age 66 years), but it was not a significant factor for recurrent CBD stones or delayed biliary emptying in this study. However the diVerent locations of major papilla around the JPD may cause diVerent hepatic clearance values and aVect risk of stone formation. 25 Further observation of large series should be conducted to stratify the patients with diVerent locations of major papilla around the JPD (especially the 3-5 and 7-9 o'clock positions) and determine their influence on biliary emptying and stone recurrence. 25 In this study, the rate of recurrence of CBD stones was higher in the non-cholecystectomised patients than in the cholecystectomised patients (17.5% versus 12.8%). The diVerence, however, was not of statistical significance probably due to an inadequate number of patients. The reasons for the observed higher recurrent rate in the non-cholecystectomised patients are not clearly understood as yet, but in this study slower biliary emptying was noted to be a significant factor for recurrence of CBD stones. Although subsequent cholecystectomy is performed in up to 21% of Western non-cholecystectomised patients after EST, emergency cholecystectomy for acute cholecystitis is performed only in about 1-6%. 1 Acute cholecystitis after EST was an uncommon complication (3%) in our noncholecystectomised patients. Only 33% of the non-cholecystectomised patients in this study had concomitant stones in the gall bladder. In addition, seven non-cholecystectomised patients did not have preexisting cholecystolithiasis and the other four non-cholecystectomised patients with preexisting cholecystolithiasis still had stones in the gall bladder at the time of recurrent CBD stones. Therefore, the recurrent stones observed in this study are more likely to be primary choledochal stones than secondary stones-that is, stones which migrated from the gall bladder.
All patients in the present study had normal liver function and were manometrically proven to have received complete sphincterotomy before QC, so the slow biliary emptying observed in some patients is not believed to be due to liver impairment or biliary obstruction. The larger diameter of the bile duct, and intact gall bladder are also likely to be factors contributing to slow biliary emptying. The major factor is, however, not clearly understood. Hindering of biliary drainage by duodenal contraction, 26 reflux of duodenal contents or radioisotopes into the bile duct through an incompetent sphincter, or abnormal hepatic excretion, are other possible factors for delayed biliary emptying on QC, but they could not be identified in this study. Further studies are required to confirm this hypothesis. As patients with a slower biliary emptying on QC have a higher incidence of recurrent CBD stones after EST, close observation is probably necessary for this subgroup of patients. 
